Results 201 to 210 of about 33,195 (264)

Cutting Through the Noise: Radiation Oncology Applicant and Program Director Response to Signaling During Match 2025. [PDF]

Adv Radiat Oncol
Mahoney MT, Dudzinski SO, Fredette JD, Choo S, Murphy J, Braunstein SE, Weiss SE, Gunther JR, Price JG, Radiation Oncology Education Collaborative Study Group (ROECSG) Undergraduate Medical Education Working Group.   +9 more
europepmc   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Anxiofit-1 and reduction of subthreshold and mild anxiety: Evaluation of a health claim pursuant to article 14 of regulation (EC) No 1924/2006. [PDF]

EFSA J
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, Bohn T, Cámara M, Castenmiller J, de Henauw S, Hirsch-Ernst KI, Jos A, Maciuk A, Mangelsdorf I, McNulty B, Naska A, Pentieva K, Thies F, Drenjančević I, Craciun I, Siani A.   +17 more
europepmc   +1 more source

Inaugural year of preference signaling in im subspecialty fellowships: multi-institutional survey about program director perceptions, benefits, and challenges. [PDF]

Med Educ Online
Narla R, Stiller R, Huppert LA.
europepmc   +1 more source

Through the Prism: Shining Light on LGBTQIA+ Applicant Identities and Influences. [PDF]

West J Emerg Med
Iuliucci K, Moujaes L, Rudolph D, Fredericks P, Denley B, Paskin S, Chung AS, Jordan J, Ordonez E, Smylie L, Li-Sauerwine S, Weygandt PL.   +11 more
europepmc   +1 more source

Safety assessment of poly(2-ethyl-2-oxazoline) for use in food contact materials. [PDF]

EFSA J
EFSA Panel on Food Contact Materials (FCM), Lambré C, Crebelli R, da Silva MJ, Grob K, Lampi E, Milana MR, Pronk M, Ščetar M, Theodoridis G, Van Hoeck E, Waegeneers N, Cariou R, Castle L, Di Consiglio E, Franz R, Barthélémy E, Comandella D, Rivière G.   +18 more
europepmc   +1 more source

Regulatory provisions for post-release monitoring of genetically modified organisms in Africa. [PDF]

Front Bioeng Biotechnol
Njagi J, Muriuki J, Mbugua P, Dass B, James S, Ogoyi D.   +5 more
europepmc   +1 more source

Efficacy of the feed additive consisting of <i>Clostridium butyricum</i>FERM BP-2789 (Miya-Gold®) for chickens for fattening, chickens reared for laying and minor poultry species (excluding laying birds) Miyarisan Pharmaceutical Co. Ltd. [PDF]

EFSA J
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, Bonos E, Christensen H, Durjava M, Dusemund B, Gehring R, Glandorf B, Kouba M, López-Alonso M, Marcon F, Nebbia C, Pechová A, Prieto-Maradona M, Theodoridou K, Anguita M, Innocenti ML, Ortuño J.   +18 more
europepmc   +1 more source